United Services Automobile Association Neurocrine Biosciences Inc Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $27,056 - $31,696	294 Added 2.9%	10,443 $1.11 Million
Q2 2022 Aug 16, 2022	BUY	$75.79 - $100.07 $769,192 - $1.02 Million	10,149 New	10,149 $990,000
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $1.17 Million - $1.41 Million	-13,929 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$72.24 - $91.27 $68,122 - $86,067	-943 Reduced 6.34%	13,929 $1.18 Million
Q1 2019 May 13, 2019	SELL	$69.31 - $91.53 $40,754 - $53,819	-588 Reduced 3.8%	14,872 $1.31 Million
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $66,612 - $121,251	975 Added 6.73%	15,460 $1.1 Million
Q3 2018 Nov 13, 2018	SELL	$98.88 - $125.85 $36,387 - $46,312	-368 Reduced 2.48%	14,485 $1.78 Million
Q2 2018 Sep 27, 2018	SELL	$75.3 - $105.99 $120 Million - $169 Million	-1,597,226 Reduced 99.08%	14,853 $1.46 Million
Q2 2018 Aug 10, 2018	BUY	$75.3 - $105.99 $120 Million - $169 Million	1,598,000 Added 11350.24%	1,612,079 $103 Million
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $1.07 Million - $1.3 Million	14,079 New	14,079 $1.17 Million

631

93.9M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.